Device Access has supported a wide range of international and European companies introducing high value medical technologies to the UK, effectively navigating the complex NHS reimbursement pathways through the creation and implementation of local and national market access strategies that demonstrate the technologies’ true value.
In 2017, Device Access became one of the first NICE approved facilitators for the MedTech Early Technical Assessment (META Tool®).
Device Access holds a licence from NHS Digital, which provides data on all hospital admissions and outcomes on a monthly basis, allowing them to work with companies to further understand the impact technologies may have on current patient populations.
AiM uses its comprehensive approach to identify the correct reimbursement pathways for a technology and to understand its potential and possible distribution channels.
AiM became part of the IGES group in 2014.
Michael founded Device Access UK in 2010 following more than 30 years experience in the sales and marketing of medical devices. Since 2010 he has driven the 30+ successful applications for NICE approvals and the submission of more than 1000 cases for change in the NHS.
Michael was one of the first qualified and approved NICE Meta Tool® facilitators.
Mehdi has over 13 years experience in market access and reimbursement and has produced over 50 economic evaluation models (CAE, CUA, Budget impact analyses) in different disease areas including cardiovascular, oncology, diabetes, ophthalmology, urology and otorhinolaryngology. Mehdi has also had over 80 publications accepted by high impact journals.
Mehdi works closely with NICE and is currently a senior advisor within the Research Design Service and a member of the Evidence Review Group.
Debbie has over 17 years experience in the NHS as a Service Improvement Manager. During her tenure she took a diploma in Innovations and Change Management and subsequently established, led and delivered a sustainable NHS innovation pathway from concept to commercialisation.
Debbie works closely with companies to develop business dossiers that support local and national market adoption of new technologies by the NHS.
Jowan runs and maintains the SQL database that continuously contains 4 years of NHS Digital hospital episode statistics. This involves managing over 1 billion data points relating to admitted patient care, accident and emergency, critical care and outpatient tables.
Jowan works with companies to provide in-depth analysis for specific patient cohorts from the hospital episode statistics.
Michael holds a Master’s equivalent in Economics from the Albert Ludwig University of Freiburg and has been working at AiM since 2009, providing consultancy to the medical technology industry.
His specialities involve reimbursement, market access and Heath Technology Assessments of diagnostic and therapeutic procedures which are based on the use of medical devices, especially in the German, Swiss and Austrian markets.
He also hosts relevant international educational workshops.
Ute has 14 years consultancy experience and holds an MSc equivalent in biochemistry from the University of Tübingen. She is responsible for systematic reviews, Health Technology Assessments, evaluation of scientific publications and medical writing.
She also undertakes the preparation of value dossiers and reimbursement-related applications for medical devices in Germany, Switzerland and Austria.
Anja holds a BSc in biomedical engineering from the Technical University of Ilmenau and an MSc in economic engineering with a specialisation in health technology from the Technical University of Berlin. Anja joined IGES group in 2016 and focuses on the benefit assessment of medical devices. She has significant experience in systematic data and literature research, stakeholder analysis, as well as application processes for OPS codes and NUB-payments.
Anja is currently undertaking her PhD at the Institute for Social Medicine, Epidemiology and Health Economics at the Charité University of Berlin where she is conducting research on the development of reimbursement of innovative products in hospitals.
Mathilda holds both a BSc and MSc in molecular biology from the Albert Ludwig University of Freiburg and Philipps-Universität Marburg. She conducts systematic reviews and reimbursement procedures as well as market access research with subsequent preparation of reimbursement dossiers for medical device technologies in the German, Swiss and Austrian markets. Prior to joining AiM, she worked as a scientist in microbiology.
Kirsten holds an MSc equivalent in biology from the University of Tübingen. She is responsible for systematic reviews and evaluation of scientific publications, as well as for market access research and subsequent preparation of reimbursement dossiers for medical device technologies. Prior to joining AiM, she worked for over 15 years as a Clinical Research Associate and Data Manager in the pharmaceutical and medical device industries.
Alison holds a BSc in Arts, German language and literature from London’s King’s College. She has 15 years’ experience in language validation for the life sciences industry, with English as her first language.